Patents by Inventor David Benditt

David Benditt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140288608
    Abstract: A method and device to enable a medical or surgical procedure using electro-cautery on a patient with an implantable device in a cautery-safe mode of operation. In one embodiment, the invention provides an electronic implantable device programmer having a computer processor, and a display screen configured to display information based on signals from the computer processor. The programmer also includes an input device, and a wireless transmitter controlled by the computer processor. The programmer display and input give the operator the option of programming an implanted electronic device in a cautery-safe mode.
    Type: Application
    Filed: June 4, 2014
    Publication date: September 25, 2014
    Inventors: Keith Lurie, Barbara S. Gold, David Benditt, Andres Belalcazar
  • Patent number: 8755902
    Abstract: A method and device to enable a medical or surgical procedure using electro-cautery on a patient with an implantable device in a cautery-safe mode of operation. In one embodiment, the invention provides an electronic implantable device programmer having a computer processor, and a display screen configured to display information based on signals from the computer processor. The programmer also includes an input device, and a wireless transmitter controlled by the computer processor. The programmer display and input give the operator the option of programming an implanted electronic device in a cautery-safe mode.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: June 17, 2014
    Assignee: ResQCor
    Inventors: Keith Lurie, Barbara S. Gold, David Benditt, Andres Belalcazar
  • Publication number: 20110160782
    Abstract: A method and device to enable a medical or surgical procedure using electro-cautery on a patient with an implantable device in a cautery-safe mode of operation. In one embodiment, the invention provides an electronic implantable device programmer having a computer processor, and a display screen configured to display information based on signals from the computer processor. The programmer also includes an input device, and a wireless transmitter controlled by the computer processor. The programmer display and input give the operator the option of programming an implanted electronic device in a cautery-safe mode.
    Type: Application
    Filed: June 3, 2010
    Publication date: June 30, 2011
    Applicant: ResQCor
    Inventors: Keith Lurie, Barbara S. Gold, David Benditt, Andres Belalcazar
  • Publication number: 20070021683
    Abstract: Embodiments of the present invention are directed to a physiological monitoring device which is configured to record signals that reflect blood flow and/or blood pressure, and which may also record ECG signals. In one embodiment, a portable monitoring device comprises a plurality of impedance electrodes configured to be coupled to a patient's body and to generate an AC current with an electrical field to detect local electrical impedance of a portion of the patient's body encompassed by the electrical field, the local electrical impedance being a surrogate measure of local blood flow of the portion of the patient's body. At least a portion of the portable monitoring device is configured to be insertable subcutaneously into the patient's body.
    Type: Application
    Filed: September 25, 2006
    Publication date: January 25, 2007
    Applicant: Transoma Medical, Inc.
    Inventors: David Benditt, Robert Patterson, Keith Lurie
  • Publication number: 20060253160
    Abstract: Devices and methods for detecting inadequate tissue perfusion by measuring a parameter other than heart rate such as vascular blood pressure, intracardiac blood pressure, vascular blood flow or tissue perfusion, in addition to or as a substitute for heart rate. Such devices and methods improve the accuracy of determining when and to what degree therapy should be administered to treat inadequate tissue perfusion, such as pre-syncope, syncope, or orthostatic hypotension, particularly in the absence of abnormal cardiac function.
    Type: Application
    Filed: July 12, 2006
    Publication date: November 9, 2006
    Applicant: Transoma Medical, Inc.
    Inventors: David Benditt, Brian Brockway, Richard Wilson
  • Publication number: 20050267381
    Abstract: Embodiments of the present invention are directed to a physiological monitoring device which is configured to record signals that reflect blood flow and/or blood pressure, and which may also record ECG signals. In one embodiment, a portable monitoring device comprises a plurality of impedance electrodes configured to be coupled to a patient's body and to generate an AC current with an electrical field to detect local electrical impedance of a portion of the patient's body encompassed by the electrical field, the local electrical impedance being a surrogate measure of local blood flow of the portion of the patient's body. At least a portion of the portable monitoring device is configured to be insertable subcutaneously into the patient's body.
    Type: Application
    Filed: May 10, 2005
    Publication date: December 1, 2005
    Applicant: Transoma Medical, Inc.
    Inventors: David Benditt, Robert Patterson, Keith Lurie
  • Patent number: 6078834
    Abstract: The invention disclosed herein relates to an implantable medical device for detection and treatment of syncope comprising an algorithm for determining the presence of syncope based on physiological activity associated with the onset of a syncopal episode, and a means for infusion a drug. Drug infusion therapy may be used along or in combination with pacing. The physiological activities detected and used by the device are selected from the group including changes in heart rate, heart rate variability, QT interval, PR interval, pressure, blood flow, vagal nerve activity, temperature, pH, and AV conduction times, respiration rate, position, motion, and combinations thereof. Drugs which may be used with the invention include pharmaceutical compositions which are capable of both endocardial administration and treatment of syncope, such as compositions comprising beta-blockers.
    Type: Grant
    Filed: February 25, 1999
    Date of Patent: June 20, 2000
    Assignee: PharmaTarget, Inc.
    Inventors: Keith G. Lurie, David Benditt, Stanislao F. Obino, Paul J. Buscemi
  • Patent number: 5919210
    Abstract: The invention disclosed herein relates to an implantable medical device for detection and treatment of syncope comprising an algorithm for determining the presence of syncope based on physiological activity associated with the onset of a syncopal episode, and a means for infusion a drug. Drug infusion therapy may be used along or in combination with pacing. The physiological activities detected and used by the device are selected from the group including changes in heart rate, heart rate variability, QT interval, PR interval, pressure, blood flow, vagal nerve activity, temperature, pH, and AV conduction times, respiration rate, position, motion, and combinations thereof. Drugs which may be used with the invention include pharmaceutical compositions which are capable of both endocardial administration and treatment of syncope, such as compositions comprising beta-blockers.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: July 6, 1999
    Assignee: PharmaTarget, Inc.
    Inventors: Keith G. Lurie, David Benditt, Stanislao F. Obino, Paul J. Buscemi